Share of Clicks for top 10 US Pharma & Biotech Research and Development brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| lilly.com | 24.8 |
| abbvie.com | 8.31 |
| ro.co | 6.21 |
| regeneron.com | 5.92 |
| pfizerforall.com | 4.93 |
| merck.com | 3.47 |
| ziphealth.co | 3.44 |
| sequencing.com | 3.29 |
| bms.com | 3.22 |
| gsk.com | 2.89 |
| others | 33.52 |
- lilly.com - 24.8%
- abbvie.com - 8.31%
- ro.co - 6.21%
- regeneron.com - 5.92%
- pfizerforall.com - 4.93%
- merck.com - 3.47%
- ziphealth.co - 3.44%
- sequencing.com - 3.29%
- bms.com - 3.22%
- gsk.com - 2.89%
- others - 33.52%
Copyright © Adthena. All rights reserved.
Lilly.com leads with 24.8% click share, while others collectively hold 33.52%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Research and Development brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | lilly.com | ro.co | pfizerforall.com | wegovy.com | ziphealth.co | evenity.com | rugiet.com | abbvie.com | hims.com | novonordisk-us.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/04/01 | 17.84% | 0.36% | 18.05% | 0.01% | 0% | 3.89% | 0% | 2.39% | 0.01% | 3.85% |
| 2026/04/02 | 24.73% | 1.07% | 16.18% | 0.01% | 0% | 3.09% | 0% | 3.58% | 0.01% | 0% |
| 2026/04/03 | 39.68% | 3.15% | 8.13% | 0.04% | 0% | 3.37% | 0% | 3.94% | 0.01% | 2.89% |
| 2026/04/04 | 34.08% | 5.08% | 9.31% | 0.07% | 0% | 3.68% | 0% | 4.85% | 0.94% | 3.29% |
| 2026/04/05 | 32.78% | 7.47% | 8.54% | 1.14% | 0% | 3.58% | 0% | 4.02% | 1.68% | 3.8% |
| 2026/04/06 | 20.34% | 6.04% | 14.28% | 1.65% | 0% | 2.58% | 0% | 2.21% | 0.15% | 4.62% |
| 2026/04/07 | 26.43% | 7.5% | 10.51% | 2.52% | 0% | 3.32% | 0% | 2.4% | 1.65% | 3.79% |
| 2026/04/08 | 15.95% | 10.68% | 12.98% | 1.43% | 0% | 5.47% | 0% | 3.33% | 0.02% | 2.89% |
| 2026/04/09 | 15.67% | 10% | 9.91% | 1.02% | 9.75% | 3.92% | 3.94% | 1.81% | 1.04% | 2.33% |
| 2026/04/10 | 20.45% | 9.63% | 10.74% | 2.14% | 6.32% | 3.59% | 3.5% | 1.77% | 0.47% | 4.95% |
| 2026/04/11 | 24.36% | 15.99% | 8.65% | 1.06% | 6.12% | 0.87% | 2.39% | 2.76% | 0.83% | 4.07% |
| 2026/04/12 | 17.03% | 16.42% | 8.11% | 0.99% | 11.11% | 2.24% | 2.85% | 3.42% | 1.4% | 4.03% |
| 2026/04/13 | 22.86% | 12.73% | 9.59% | 0.02% | 5.62% | 2.03% | 2.48% | 2.77% | 0.6% | 0.59% |
| 2026/04/14 | 16.76% | 15.95% | 8.24% | 3.18% | 6.92% | 3.34% | 2.63% | 1.39% | 3.24% | 3.77% |
| 2026/04/15 | 15.21% | 16.46% | 6.69% | 2.15% | 8.19% | 3.3% | 3.96% | 1.48% | 2.42% | 2.39% |
| 2026/04/16 | 14.69% | 15.53% | 5.89% | 2.16% | 8.91% | 3.11% | 4.09% | 1.94% | 1.87% | 1.54% |
| 2026/04/17 | 25.46% | 12.45% | 7.16% | 1.02% | 7.73% | 2.33% | 3.54% | 1.01% | 1.88% | 0.59% |
| 2026/04/18 | 26.48% | 10.29% | 6.22% | 4.52% | 8.32% | 2.63% | 2.96% | 2.35% | 2.12% | 0% |
| 2026/04/19 | 25.45% | 9.74% | 8.88% | 2.93% | 6.2% | 1.03% | 2.47% | 3.53% | 2.08% | 0% |
| 2026/04/20 | 21.16% | 11.1% | 9.23% | 0.03% | 7.1% | 2.71% | 2.66% | 0.35% | 2.2% | 0% |
| 2026/04/21 | 21.13% | 9.19% | 10.05% | 3.82% | 3.65% | 3.11% | 1.72% | 2.24% | 1.17% | 0% |
| 2026/04/22 | 17.6% | 12.68% | 8.38% | 3.24% | 6.93% | 3.79% | 3.56% | 1.36% | 1.58% | 0% |
| 2026/04/23 | 17.55% | 12.91% | 8.1% | 2.4% | 6.07% | 2.33% | 3.04% | 1.33% | 2.62% | 0% |
| 2026/04/24 | 27.4% | 13.54% | 7.67% | 0.05% | 4.27% | 1.99% | 2.13% | 1.23% | 1.43% | 0% |
| 2026/04/25 | 30.4% | 15.07% | 6.93% | 1.04% | 3.67% | 2.08% | 2.15% | 1.77% | 2.52% | 0% |
| 2026/04/26 | 22.8% | 13.17% | 6.7% | 1.07% | 5.28% | 2.68% | 2.14% | 3.53% | 2.76% | 0% |
| 2026/04/27 | 28.14% | 8.51% | 8.72% | 1.14% | 5.52% | 3.62% | 2.38% | 0.7% | 1.58% | 0% |
| 2026/04/28 | 19.97% | 16.36% | 9.21% | 2.38% | 5.89% | 2.1% | 1.92% | 1.64% | 1.58% | 0% |
| 2026/04/29 | 20.11% | 14.29% | 9.41% | 3.18% | 5.27% | 2.23% | 1.99% | 1.01% | 1.33% | 0% |
| 2026/04/30 | 23.26% | 16.21% | 7.46% | 4.83% | 4.5% | 4.32% | 1.95% | 1.38% | 0.81% | 0% |
- lilly.com
- ro.co
- pfizerforall.com
- wegovy.com
- ziphealth.co
- evenity.com
- rugiet.com
- abbvie.com
- hims.com
- novonordisk-us.com
Copyright © Adthena. All rights reserved.
Lilly.com led April with fluctuating spend, peaking at 39.68% on April 3. Ro.co steadily increased, while Pfizerforall.com saw a decline. Wegovy.com and Ziphealth.co showed modest gains. April ended with diverse spending patterns.
Competitor Count for US Pharma & Biotech Research and Development
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/04/01 | 432 |
| 2026/04/02 | 452 |
| 2026/04/03 | 469 |
| 2026/04/04 | 456 |
| 2026/04/05 | 460 |
| 2026/04/06 | 471 |
| 2026/04/07 | 476 |
| 2026/04/08 | 476 |
| 2026/04/09 | 475 |
| 2026/04/10 | 475 |
| 2026/04/11 | 446 |
| 2026/04/12 | 455 |
| 2026/04/13 | 486 |
| 2026/04/14 | 475 |
| 2026/04/15 | 456 |
| 2026/04/16 | 427 |
| 2026/04/17 | 438 |
| 2026/04/18 | 432 |
| 2026/04/19 | 437 |
| 2026/04/20 | 450 |
| 2026/04/21 | 455 |
| 2026/04/22 | 450 |
| 2026/04/23 | 454 |
| 2026/04/24 | 456 |
| 2026/04/25 | 447 |
| 2026/04/26 | 445 |
| 2026/04/27 | 457 |
| 2026/04/28 | 460 |
| 2026/04/29 | 458 |
| 2026/04/30 | 447 |
Copyright © Adthena. All rights reserved.
April began with 432 advertisers, peaking at 486 mid-month. Fluctuations followed, ending at 447.
